Additional file 1: Fig. S1. of Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

CONSORT 2010 Flow Diagram. (DOCX 36 kb

Additional file 4: Table S3. of Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

Adverse effects. (DOCX 20 kb

Additional file 3: of Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes

Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal A - ER positive, PR positive, HER2 negative, and Ki-67 < 20%; Luminal B - ER positive and/or PR positive, HER2 positive (or HER2 negative and Ki-67 ≥ 20% or PR negative); HER2-enriched - ER negative, PR negative, and HER2 positive; and TNBC - ER negative, PR negative and HER2 negative. Abbreviations: ER, estrogen receptor; HER2, human epidermal growth factor receptor-2; PR, progesterone receptor; TNBC, triple negative breast cancer (PDF 215 kb

Additional file 4: of Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes

Table S2. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and breast cancer-free interval by pre-diagnostic triglycerides among HER2+ patients (DOCX 16 kb

Additional file 2: of Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes

Figure S1. Age-adjusted overall survival by breast cancer molecular subtypesa. a Luminal A - ER positive, PR positive, HER2 negative, and Ki-67 < 20%; Luminal B - ER positive and/or PR positive, HER2 positive (or HER2 negative and Ki-67 ≥ 20% or PR negative); HER2-enriched - ER negative, PR negative, and HER2 positive; and TNBC - ER negative, PR negative and HER2 negative. Abbreviations: ER, estrogen receptor; HER2, human epidermal growth factor receptor-2; PR, progesterone receptor; TNBC, triple negative breast cancer (PDF 215 kb

Additional file 5: of Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes

Table S3. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and breast cancer-free interval by pre-diagnostic triglycerides/HDL-cholesterol ratio among triple negative breast cancer (TNBC) patients (DOCX 16 kb